Skip to main content
Log in

Valproate-related hyperammonemic encephalopathy with generalized suppression EEG: a case report

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract    

Background

Valproic acid (VPA) is a prevalent antiseizure medication (ASM) used to treat epilepsy. Valproate-related hyperammonemic encephalopathy (VHE) is a type of encephalopathy that can occur during neurocritical situations. In VHE, the electroencephalogram (EEG) displays diffuse slow waves or periodic waves, and there is no generalized suppression pattern.

Case presentation

We present a case of a 29-year-old female with a history of epilepsy who was admitted for convulsive status epilepticus (CSE), which was controlled by intravenous VPA, as well as oral VPA and phenytoin. The patient did not experience further convulsions but instead developed impaired consciousness. Continuous EEG monitoring revealed a generalized suppression pattern, and the patient was unresponsive. The patient’s blood ammonia level was significantly elevated at 386.8 μmol/L, indicating VHE. Additionally, the patient’s serum VPA level was 58.37 μg/ml (normal range: 50–100 μg/ml). After stopping VPA and phenytoin and transitioning to oxcarbazepine for anti-seizure and symptomatic treatment, the patient’s EEG gradually returned to normal, and her consciousness was fully restored.

Discussion

VHE can cause the EEG to display a generalized suppression pattern. It is crucial to recognize this specific situation and not to infer a poor prognosis based on this EEG pattern.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

Not applicable.

References 

  1. Wu J, Li J, Jing W et al (2021) Valproic acid-induced encephalopathy: a review of clinical features, risk factors, diagnosis, and treatment. Epilepsy Behav EB 120:107967. https://doi.org/10.1016/j.yebeh.2021.107967

    Article  Google Scholar 

  2. Segura-Bruna N, Rodriguez-Campello A, Puente V, Roquer J (2006) Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand 114:1–7. https://doi.org/10.1111/j.1600-0404.2006.00655.x

    Article  CAS  PubMed  Google Scholar 

  3. Cherian KA, Legatt AD (2017) Burst suppression pattern on electroencephalogram secondary to valproic acid-induced hyperammonemic encephalopathy. Pediatr Neurol 73:88–91. https://doi.org/10.1016/j.pediatrneurol.2016.12.011

    Article  PubMed  Google Scholar 

  4. Alkhachroum A, Appavu B, Egawa S et al (2022) Electroencephalogram in the intensive care unit: a focused look at acute brain injury. Intensive Care Med 48:1443–1462. https://doi.org/10.1007/s00134-022-06854-3

    Article  PubMed  Google Scholar 

  5. Young GB (2000) The EEG in coma. J Clin Neurophysiol Off Publ Am Electroencephalogr Soc 17:473–485. https://doi.org/10.1097/00004691-200009000-00006

    Article  CAS  Google Scholar 

  6. Young GB, McLachlan RS, Kreeft JH, Demelo JD (1997) An electroencephalographic classification for coma. Can J Neurol Sci J Can Sci Neurol 24:320–325. https://doi.org/10.1017/S0317167100032996

    Article  CAS  Google Scholar 

  7. E T, M L (2015) Which EEG patterns in coma are nonconvulsive status epilepticus? Epilepsy Behav EB 49. https://doi.org/10.1016/j.yebeh.2015.05.005

  8. Shanker A, Abel JH, Schamberg G, Brown EN (2021) Etiology of burst suppression EEG patterns. Front Psychol 12:673529. https://doi.org/10.3389/fpsyg.2021.673529

    Article  PubMed  PubMed Central  Google Scholar 

  9. The postictal state — what do we know? - Pottkämper - 2020 - Epilepsia - Wiley Online Library. https://onlinelibrary.wiley.com/doi/10.1111/epi.16519. Accessed 15 Dec 2022

  10. Asadollahi M, Noorbakhsh M, Simani L et al (2018) Two predictors of postictal generalized EEG suppression: tonic phase duration and postictal immobility period. Seizure 61:135–138. https://doi.org/10.1016/j.seizure.2018.08.009

    Article  PubMed  Google Scholar 

  11. Tripp JH, Hargreaves T, Anthony PP et al (1981) Sodium valproate and ornithine carbamyl transferase deficiency. Lancet Lond Engl 1:1165–1166. https://doi.org/10.1016/s0140-6736(81)92338-2

    Article  CAS  Google Scholar 

  12. Oechsner M, Steen C, Stürenburg HJ, Kohlschütter A (1998) Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency. J Neurol Neurosurg Psychiatry 64:680–682. https://doi.org/10.1136/jnnp.64.5.680

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Noh Y, Kim DW, Chu K et al (2013) Topiramate increases the risk of valproic acid-induced encephalopathy. Epilepsia 54:e1-4. https://doi.org/10.1111/j.1528-1167.2012.03532.x

    Article  CAS  PubMed  Google Scholar 

  14. Deutsch SI, Burket JA, Rosse RB (2009) Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate. Clin Neuropharmacol 32:350–352. https://doi.org/10.1097/WNF.0b013e3181ac3615

    Article  PubMed  Google Scholar 

  15. Woo PYM, Woo AWY, Lam SW et al (2020) Incidence, presentation, and risk factors for sodium valproate-associated hyperammonemia in neurosurgical patients: a prospective, observational study. World Neurosurg 144:e597–e604. https://doi.org/10.1016/j.wneu.2020.09.027

    Article  PubMed  Google Scholar 

  16. Iqbal K, Kummamuru H, Dasari N et al (2021) A case of valproic-acid induced hyperammonemic encephalopathy. Cureus 13:e20380. https://doi.org/10.7759/cureus.20380

    Article  PubMed  PubMed Central  Google Scholar 

  17. Elwadhi D, Prakash R, Gupta M (2017) The menacing side of valproate: a case series of valproate-induced hyperammonemia. Indian J Psychol Med 39:668–670. https://doi.org/10.4103/0253-7176.217033

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was funded by KuanRen Outstanding Young Talent Program of the Second.

Affiliated Hospital of Chongqing Medical University (KY2019Y006).

Author information

Authors and Affiliations

Authors

Contributions

XP provided the ideas and revised the manuscript. XL searched and reviewed articles related to valproate-related hyperammonemic encephalopathy and malignant EEG patterns, summarized the views, and wrote the manuscript. Both authors read and approved the final manuscript.

Corresponding author

Correspondence to Xi Peng.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

The participant has consented to the submission of the case report to the journal.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, X., Peng, X. Valproate-related hyperammonemic encephalopathy with generalized suppression EEG: a case report. Neurol Sci 44, 3669–3673 (2023). https://doi.org/10.1007/s10072-023-06865-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-06865-y

Keywords

Navigation